VISTIDE er indiceret til behandling af CMV- retinitis hos patienter med acquired immunodeficiency syndrome (AIDS) og uden nyreinsufficiens.
VISTIDE is indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) and without renal dysfunction.